Seema Sheoran
Stock Analyst at Rodman & Renshaw
(1.94)
# 3,141
Out of 4,361 analysts
4
Total ratings
25%
Success rate
5.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Seema Sheoran
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVXL Anavex Life Sciences | Initiated Coverage: Buy | $20 | $2.79 | +618.13% | 1 | May 4, 2026 | |
| CAMP Camp4 Therapeutics | Initiated Coverage: Buy | $7 | $3.97 | +76.32% | 1 | Apr 14, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $13 | $3.48 | +273.56% | 1 | Apr 2, 2026 | |
| SGMT Sagimet Biosciences | Initiated Coverage: Buy | $28 | $6.79 | +312.37% | 1 | Mar 26, 2026 |
Anavex Life Sciences
May 4, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $2.79
Upside: +618.13%
Camp4 Therapeutics
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $3.97
Upside: +76.32%
SAB Biotherapeutics
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $3.48
Upside: +273.56%
Sagimet Biosciences
Mar 26, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $6.79
Upside: +312.37%